Our mission is to leverage AI to profile, within minutes, a broad range of biomarkers from the H&E image alone. By doing so, we can overcome economical, logistical, and technological barriers to reach the full potential of precision medicine for cancer patients.
Lawrence J. Ellison Institute for Transformative Medicine
"This is a breakthrough technology that has been tested in deep collaboration with the physicians of our pathology lab"
Sheba Medical Center
“Unfortunately, we are so used to waiting a long time for molecular cancer testing while patients deteriorate, that such a breakthrough technology, enabling treatment initiation within a day is exceptional.”
Tel Aviv Sourasky Medical Center
“The pathology dept. at Ichilov participates in research and development of many new and advanced technologies, but it is rarely that we see a direct and meaningful impact on patients’ lives. We are excited about the opportunity to partner with Imagene to improve quality of care and impact patients’ lives.”
Tel Aviv Sourasky Medical Center
"Cancer diagnosis focuses on pathological and molecular testing. I believe that no structure and assumptions should become a barrier to personal treatment. Imagene brings the potential of accurate, fast, actionable, standardized screening to all cancer patients."
Shaare Zedek Medical Center
“Our team is proud to be part of Imagene’s mission to leverage AI in the fight against cancer. The ongoing digitization of healthcare will reward medical providers, payers and patients with new ways of leveraging data to improve diagnoses, treatments and outcomes”
Blumberg Capital
"After seeing the same type of transformation in the AI medical imaging space, we are certain that Imagene is well positioned to disrupt the pathology biomarkers space with its unique AI platform and data assets.”
Standardize, accelerate and reduce costs of drug development through deep learning for clinical trials
lmagene's state-of-the-art deep learning models have the capabilities of searching for all present phenotypic alterations and empowering the reporting of meaningful insights.
We make no assumptions. our models rely on prospective data and unsupervised learning to provide the highest sensitivity and specificity rates.
“Imagene’s technology can unlock precise and crucial information in real-time, changing the way cancer is diagnosed and treated.”